Exploring the principles behind antibiotics with limited resistance

  05 March 2025

The study suggests that dual targeting of antibiotics is not enough to prevent bacterial resistance. Only those that target membrane integrity and block another cellular pathway show reduced resistance development. The study tested three antibiotic candidates, POL7306, Tridecaptin M152-P3, and SCH79797, and found that resistance evolution against these antibiotics is limited in ESKAPE pathogens. The study provides guidelines for future antibiotic development.

Further reading: Nature Communications
Author(s): Elvin Maharramov et al
Smart Innovations  
Back

OUR UNDERWRITERS

Unrestricted financial support by:

Antimicrobial Resistance Fighter Coalition

Bangalore Bioinnovation Centre

INTERNATIONAL FEDERATION PHARMACEUTICAL MANUFACTURERS & ASSOCIATIONS

BD





AMR NEWS

Your Biweekly Source for Global AMR Insights!

Stay informed with the essential newsletter that brings together all the latest One Health news on antimicrobial resistance. Delivered straight to your inbox every two weeks, AMR NEWS provides a curated selection of international insights, key publications, and the latest updates in the fight against AMR.

Don’t miss out on staying ahead in the global AMR movement—subscribe now!

Subscribe
What is going on with AMR?
Stay tuned with remarkable global AMR news and developments!